Friday, 31 July 2020

Pharma giant Merck raises 2020 outlook, saying the worst of the coronavirus impact is behind it

Sales of Merck's blockbuster cancer drug Keytruda helped offset an 8% decline in revenue to $10.87 billion during second quarter from $11.76 billion from a year earlier.

from Earnings https://ift.tt/3hU5n0a
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)